/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

style
pb-0

ENVERIC BIOSCIENCES INC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0
$5.85 0.0137(1.37%) ENVB at 04 Dec 2025 04:30 PM Biotechnology
Lowest Today 5.72
Highest Today 5.81
Today’s Open 5.72
Prev. Close 5.82
52 Week High 96.30
52 Week Low 4.88
Day’s Range: Low 5.72 High 5.81
52-Week Range: Low 4.88 High 96.30
1 day return -
1 Week return -
1 month return +0.52
3 month return +460.78
6 month return +340.0
1 year return +1660.0
3 year return +92.59
5 year return -98.16
10 year return -

Institutional Holdings

AdvisorShares Psychedelics ETF 6.27

AdvisorShares Investments, LLC 3.19

Renaissance Technologies Corp 1.14

Geode Capital Management, LLC 0.87

UBS Group AG 0.84

Virtu Financial LLC 0.64

Morgan Stanley - Brokerage Accounts 0.40

Fidelity Extended Market Index 0.39

Fidelity Nasdaq Composite Index 0.34

Fidelity Series Total Market Index 0.14

Tower Research Capital LLC 0.09

Vanguard Institutional Extnd Mkt Idx Tr 0.03

BlackRock Inc 0.02

SBI Securities Co Ltd 0.02

Spartan Extended Market Index Pool F 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

Barclays PLC 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

Bank of America Corp 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

SSgA U.S. Total Market Index Strategy 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

NT Ext Eq Mkt Indx Fd DC Lend T3 0.00

Wells Fargo & Co 0.00

Citadel Advisors Llc 0.00

FMR Inc 0.00

Group One Trading, LP 0.00

Headlands Technologies LLC 0.00

HRT FINANCIAL LLC 0.00

JONES FINANCIAL COMPANIES LLLP 0.00

Nelson, Van Denburg & Campbell Wealth Management Group, LLC 0.00

Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 2.83 M

PB Ratio 0.9759

PE Ratio 0.0

Enterprise Value -0.34 M

Total Assets 3.08 M

Volume 20507

Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:39914675 39.9M, FY19:39914675 39.9M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:-656643000 -656.6M, FY20:8150720 8.2M, FY19:8150720 8.2M

Annual Net worth FY23:-22565342 -22.6M, FY22:-18471333 -18.5M, FY21:-48976896 -49.0M, FY20:-6386945 -6.4M, FY19:-5603975 -5.6M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:-40369 -0.0M, Q2/2025:-39980 -0.0M, Q1/2025:-81024 -0.1M, Q3/2024:null 0.0M, Q2/2024:-84779 -0.1M

Quarterly Net worth Q3/2025:-1873669 -1.9M, Q2/2025:-2519181 -2.5M, Q1/2025:-2184966 -2.2M, Q3/2024:-2084032 -2.1M, Q2/2024:-1879394 -1.9M

Fund house & investment objective

Company Information Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. The company offers product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. It also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. The company was founded in 2020 and is headquartered in Cambridge, Massachusetts.

Organisation Biotechnology

Employees 5

Industry Biotechnology

CEO Dr. Joseph Edward Tucker Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow